RecruitingNot ApplicableNCT07343011

Conjunctival Transpositional Surgery for Primary Pterygium

Conjunctival Transpositional Pterygium Surgery: A Prospective Single-Arm Interventional Study


Sponsor

Zahedan University of Medical Sciences

Enrollment

70 participants

Start Date

May 21, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

This prospective single-arm interventional study evaluates the recurrence rate and functional outcomes following conjunctival transpositional pterygium surgery without bare sclera formation. The technique involves mobilization and transposition of the pterygium tissue while preserving Tenon's layer and avoiding adjunctive therapies.


Eligibility

Min Age: 18 Years

Inclusion Criteria3

  • Adults aged 18 years or older
  • Primary pterygium involving the cornea
  • Ability to provide informed consent

Exclusion Criteria4

  • Recurrent pterygium
  • Previous ocular surface surgery
  • Active ocular infection or inflammation
  • Severe ocular surface disease

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREConjunctival Transpositional Pterygium Surgery

A conjunctival incision was created at the upper and lower limbus to allow adequate tissue mobilization. The pterygium tissue is dissected off the corneal surface without complete excision or creation of a bare sclera defect. The fibrovascular tissue is mobilized and transposed inferiorly within the subconjunctival plane and secured with absorbable sutures. Tenon's tissue is preserved, and no adjunctive therapy is used.


Locations(1)

Alzahra Eye Hospital, Zahedan University of Medical Sciences

Zahedan, Sistan and Balochistan, Iran

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07343011